298. Hereditary pancreatitis Clinical trials / Disease details


Clinical trials : 98 Drugs : 180 - (DrugBank : 57) / Drug target genes : 53 - Drug target pathways : 142

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00559364
(ClinicalTrials.gov)
November 200714/11/2007Safety and Efficacy Study of Viokase® 16 for the Correction of SteatorrheaA Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled, Phase III Study to Assess the Safety and Efficacy of Viokase® 16 for the Correction of Steatorrhea in Patients With Exocrine Pancreatic InsufficiencyExocrine Pancreatic Insufficiency;Chronic Pancreatitis;PancreatectomyDrug: Viokase® 16;Drug: Placebo;Drug: Proton pump inhibitor (PPI);Drug: OmeprazoleForest LaboratoriesNULLCompleted18 Years80 YearsAll50Phase 3United States;Canada;Poland;Slovakia;Germany